This new Botox alternative promises results that last twice as long as its competitors. So—what do actual dermatologists think?
was used to simply help people who had strabismus, or crossed eyes. But as is the case with some of the most brilliant medical innovations, doctors noticed that wrinkles between the eyes, aka the 11-lines or glabella, were disappearing with treatment. Botox, as we know it, was a happy accident. Fast forward to today, and using FDA-approved neuromodulators for cosmetic purposes is common practice—and innovation is at an all-time high.
But, because of this peptide surrounding it, Daxxify can go a step further. “It doesn't get washed away as quickly. It stays in that synaptic junction and allows for a longer duration of action,” she explains. In practice, dermatologists and patients are also noticing that the effects are taking hold quicker, with complete results visible in just around 48 hours. That said, there is no data to support this observation.
The second cohort that are great candidates are individuals that can’t make it to the dermatologist for retouches every three months. Maybe they live abroad, are traveling, or have back to back special events that prevent them from paying a visit to the office. The third group is interestingly enough women who are trying to get pregnant. “We don't do cosmetic treatments on patients who are pregnant,” says Dr. Marchbein.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Williamsburg’s Newest Rooftop LilliStar Packs a Tropical PunchGet a solid dose of vitamin D and immaculate views at this sky-high spot (via Thrillist)
Les mer »
New Jersey can make some lemonade out of our newest lemon of a law | OpinionUnder the brand new Election Transparency Act, ethically challenged candidates can avoid violations by simply avoiding disclosing their campaign spending for two years.
Les mer »
Celebrating National Minority Health Month with Dr. Namandjé BumpusDr. Namandjé Bumpus, Chief Scientist of the FDA, has been a first in almost everything she’s done. But for her, success will mean that she’s not the last. See how she’s breaking glass ceilings for those who are underrepresented in science at WeCanDoThis
Les mer »
Breast implants tied to rare cancer to remain on U.S. marketThere have been more than 600 of these cancer cases worldwide, but the FDA decided against a ban
Les mer »
FDA issues strong warning over risks of common sleeping pillsSome prescription sleeping pills like Ambien and Lunesta will now come with a prominent warning slapped on the box
Les mer »